Latest News

Paxman In 5 Best-Ranked Cancer Centres In USA

Paxman In 5 Best-Ranked Cancer Centres In USA

PAXMAN announces that the company now has signed delivery agreements in the USA for its leading scalp cooling system with all of the five highest-ranked cancer treatment centres according to U.S. News & World Report’s annual ranking.

read more

Helps Cancer Patient Avoid Hair Loss

A Seattle woman has spoken out about her experience of using the Paxman Scalp Cooler System. Brynn Kemper was just 29-year-old when she was diagnosed with breast cancer. She used the Paxman Scalp Cooling System before, during and after the administration of chemotherapy to help retain her hair.

read more
Paxman shortlisted for two TAG Awards

Paxman shortlisted for two TAG Awards

Paxman have been shortlisted in two categories for this year’s BritishAmerican Business TransAtlantic Growth (TAG) Awards – Small Gold Export Award and Family Run Business Silver Award.

read more

Exporting is GREAT – Paxman

According to The Yorkshire Post, UK exports have been shown to have risen by 11.3 per cent to £617bn when comparing Office for National Statistics (ONS) data from 2017 versus 2016.

Trade of goods with non-EU countries grew by 11.6 per cent, faster than with the EU at 10.9 per cent.

Paxman are justifiably proud to be credited as part of this surge and exported to 26 countries across five continents in 2017.

read more
Mexico Market Licensing Agreement

Mexico Market Licensing Agreement

PAXMAN and Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) have announced the signing of an exclusive licensing agreement for PAXMAN Scalp Cooler treatments in the Mexico market. Under the agreement, Teva will be responsible for the sales and marketing activities in Mexico.

read more